Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
“Mini-mental state”
1975 • 82,784 citations
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 • 19,723 citations
ECDEU Assessment Manual for Psychopharmacology
1976 • 8,729 citations
A depression rating scale for schizophrenics
1990 • 1,199 citations
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial
1997 • 906 citations
Risk of Tardive Dyskinesia in Older Patients
1995 • 302 citations
Influence of the autonomic nervous system on the Q-T interval in man
1982 • 245 citations
Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic Patients
1996 • 120 citations
Extrapyramidal Signs and Clinical Symptoms in First-Episode Schizophrenia
1997 • 106 citations
Efficacy of olanzapine: an overview of pivotal clinical trials.
1997 • 102 citations
Experience with the atypical antipsychotics--risperidone and olanzapine in the elderly.
1999 • 58 citations
New Atypical Antipsychotics
1998 • 50 citations
Prospective study of tardive dyskinesia in the elderly
1990 • 48 citations
First clinical experience with olanzapine (LY 170053)
1995 • 41 citations
Clinical Assessment of Extrapyramidal Signs in Nursing Home Patients Given Antipsychotic Medication
1994 • 41 citations
Therapeutic Equivalence of Risperidone Given Once Daily and Twice Daily in Patients With Schizophrenia
1998 • 34 citations
Olanzapine therapy in elderly patients with schizophrenia.
1998 • 29 citations
Long QT syndrome.
1992 • 29 citations
[Olanzapine. A new antipsychotic agent].
1997 • 1 citations